 |
|
AQUAMANTYS® System - Economic Value for Surgeons and HospitalsSalient Surgical’s patented TRANSCOLLATION® technology is an advanced solution that provides haemostasis during many types of surgery. We recognize that healthcare providers have various options available to manage blood loss and patient hemoglobin levels perioperatively, and we remain committed to delivering improved clinical outcomes while saving money for hospitals.The tables below represent hospital national-average costs for transfusions and length of stay (LOS) from the MedPAR database.1 Salient’s TRANSCOLLATION technology has been shown to provide clinical benefits and reduced transfusion rates, which drives lower costs to the hospital.*  Salient’s Impact on Transfusion Rates and Blood LossBlood transfusions are known to increase the likelihood of post-surgical infections in patients and therefore contribute to increased length of hospital stay.1 TRANSCOLLATION® technology has been clinically shown to reduce transfusion rates by minimizing intra-operative blood loss in hip, knee, spine and liver procedures. **,2,3,4Salient will work with your institution to create a customized economic analysis showing the potential value of adding TRANSCOLLATION technology to your procedures. Please contact your local sales representative or our toll free number 800-777-9400 for additional information. *Performance has not been specifically established with the AQUAMANTYS System. **Performance has not been specifically established in all procedures. View References |